🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of 2 doses ...
Status
Active Not Recruiting
Location
Childrens Healthcare of Atlanta
Start Date
2019-07-26
Trial ID
NCT03814746
Treatments Being Tested
This is a multi-center multi-national rollover study to allow continued acc...
Status
Recruiting
Location
University Of Alabama
Start Date
2021-06-10
Trial ID
NCT04657822
Treatments Being Tested
The purpose of this study was to confirm and to establish appropriate dosin...
Status
Completed
Location
University Of Alabama
Start Date
2018-10-01
Trial ID
NCT03474965
Treatments Being Tested
The purpose of this study was to investigate the safety, pharmacokinetics a...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-09-26
Trial ID
NCT04097821
Treatments Being Tested
The purpose of this registration is to list Managed Access Programs (MAPs) ...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT03720626
Treatments Being Tested
Sickle cell disease (SCD) is a genetic blood disorder. Crizanlizumab is ind...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-14
Trial ID
NCT04662931
Treatments Being Tested
The goal of the study was to evaluate descriptively the effect of crizanliz...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2019-12-10
Trial ID
NCT04053764
Treatments Being Tested
The purpose of the CSEG101A2202 study was to characterize the Pharmacokinet...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-12-19
Trial ID
NCT03264989
Treatments Being Tested
The goal of the study was to evaluate the efficacy and safety of crizanlizu...
Status
Completed
Location
University Of Alabama
Start Date
2019-10-16
Trial ID
NCT03938454
Treatments Being Tested
A phase III, multi-center, randomized, placebo-controlled, double-blind stu...
Status
Recruiting
Location
University Of Alabama
Start Date
2024-10-24
Trial ID
NCT06439082
Treatments Being Tested